Skip to main content
 

AHA Innovators’ Network Member Biobeat’s RPM Devices and Platform Receive FDA Clearances for Stroke Volume and Cardiac Output

AHA Innovators’ Network Member Biobeat’s RPM Devices and Platform Receive FDA Clearances for Stroke Volume and Cardiac Output

Innovators’ Network member company Biobeat, announced that its wearable remote patient monitoring devices have received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to monitor stroke volume and cardiac output in addition to cuffless blood pressure, blood oxygen saturation, pulse rate, respiratory rate and body temperature.  Read more here.

More News

  • Artificial Intelligence in the Clinic: Don’t Pay for the Tool, Pay for the Care

  • Brainomix Extends Series C Financing to $25.4M to Support U.S. Expansion

  • Dr. Eric Topol’s mentions CureMetrix: All Mammograms Should Incorporate A.I. | CureMetrix